| SCHEDULE OF PREVIOUSLY REPORTED CONSOLIDATED FINANCIAL STATEMENTS |
SCHEDULE
OF PREVIOUSLY REPORTED CONSOLIDATED FINANCIAL
STATEMENTS
Consolidated
Balance Sheet
(in
thousands)
As
of December 31, 2023
| |
|
As Previously |
|
|
Revision |
|
|
As |
|
| |
|
Reported |
|
|
Adjustments |
|
|
Revised |
|
| Assets |
|
|
|
|
|
|
|
|
|
|
|
|
| Current Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
| Cash and cash equivalents |
|
$ |
121,691 |
|
|
$ |
(22,970 |
) |
|
$ |
98,721 |
|
| Marketable securities |
|
$ |
- |
|
|
$ |
22,970 |
|
|
$ |
22,970 |
|
| Total Current Assets |
|
$ |
221,734 |
|
|
$ |
- |
|
|
$ |
221,734 |
|
| Total Assets |
|
$ |
428,519 |
|
|
$ |
- |
|
|
$ |
428,519 |
|
Consolidated
Statement of Cash Flows
(in
thousands)
For
The Year Ended December 31, 2023
| |
|
As Previously |
|
|
Revision |
|
|
As |
|
| |
|
Reported |
|
|
Adjustments |
|
|
Revised |
|
| Cash Flows From Investing Activities: |
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from sale of marketable securities |
|
$ |
- |
|
|
$ |
16,442 |
|
|
$ |
16,442 |
|
| Net Cash Used In Investing Activities |
|
$ |
(13,240 |
) |
|
$ |
(22,970 |
) |
|
$ |
(36,210 |
) |
| Net Increase In Cash and Cash Equivalents and Restricted Cash |
|
$ |
85,137 |
|
|
$ |
(22,970 |
) |
|
$ |
62,167 |
|
| Cash and Cash Equivalents and Restricted Cash - Beginning of Year |
|
$ |
36,633 |
|
|
$ |
- |
|
|
$ |
36,633 |
|
| Cash and Cash Equivalents and Restricted Cash - End of Year |
|
$ |
121,770 |
|
|
$ |
(22,970 |
) |
|
$ |
98,800 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Cash and cash equivalents and restricted cash consisted of the following: |
|
|
|
|
|
|
|
|
|
|
|
|
| Cash and cash equivalents |
|
$ |
121,691 |
|
|
$ |
(22,970 |
) |
|
$ |
98,721 |
|
| Restricted cash |
|
$ |
79 |
|
|
$ |
- |
|
|
$ |
79 |
|
| Cash and Cash Equivalents
and Restricted Cash - End of Year |
|
$ |
121,770 |
|
|
$ |
(22,970 |
) |
|
$ |
98,800 |
|
|